Detalles de la búsqueda
1.
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas.
Br J Haematol
; 204(1): 151-159, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690811
2.
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphoma.
Am J Hematol
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38700035
3.
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.
Cancer
; 129(2): 255-263, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36385707
4.
Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome.
Haematologica
; 107(5): 1153-1162, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289655
5.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320921
6.
CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).
Haematologica
; 106(11): 2918-2926, 2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054126
7.
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
Am J Hematol
; 94(6): 628-634, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30829413
8.
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial including Rituximab in the Reduced-Intensity Conditioning Regimen.
Biol Blood Marrow Transplant
; 23(7): 1102-1109, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28390983
9.
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study.
Hematol Oncol
; 40(2): 307-309, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023190
10.
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by PET scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma.
Biol Blood Marrow Transplant
; 20(12): 1982-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25240818
11.
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(6): 885-90, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24583412
12.
Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in patients with lymphoma.
Blood Adv
; 8(8): 1968-1980, 2024 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359407
13.
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Leukemia
; 38(5): 1107-1114, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38459167
14.
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 19(3): 424-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23142330
15.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653509
16.
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Br J Haematol
; 158(1): 108-19, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571717
17.
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports.
Haematologica
; 102(10): e423-e426, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28659333
18.
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
Ann Hematol
; 91(6): 931-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22245922
19.
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma.
Clin Cancer Res
; 28(15): 3378-3386, 2022 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583610
20.
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi.
J Clin Oncol
; 40(35): 4060-4070, 2022 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35714311